The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions-Reference-Cited by-同舟云学术

The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions

Published:2003-09 Issue:1 Volume:105 Page:79-88
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Naef Myrtha,Curatolo Michele,Petersen-Felix Steen,Arendt-Nielsen Lars,Zbinden Alex,Brenneisen Rudolf

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference45 articles.

1. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system.;Arendt-Nielsen;Eur J Appl Physiol Occup Physiol,1994

2. Effect of racemic mixture and the (S)-isomer of ketamine on temporal and spatial summation of pain.;Arendt-Nielsen;Br J Anaesth,1996

3. Diacetylmorphine and its metabolites in plasma by HPLC with diode-array and atmospheric pressure ionization mass spectrometric detection.;Bourquin;J Liq Chromatogr Rel Technol,1999

4. The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with two patients.;Brenneisen;Int J Clin Pharmacol Ther,1996

5. Measurements of human pressure-pain thresholds on fingers and toes.;Brennum;Pain,1989

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within‐subject, randomized, placebo‐controlled laboratory study;Addiction Biology;2023-07-30

2. Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence;International Review of Psychiatry;2023-06-28

3. Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain;Neuropsychopharmacology;2023-05-18

4. Inhaled Δ9-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers;British Journal of Anaesthesia;2023-04

5. Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination—the SPIRAL study;Trials;2023-01-27